Alice Blue - 20 years of trust
    • ANT APP
    • ANT WEB
    • 1LyAlgos
    • 1lyOptions
    • TradingView
    • MTF
    • Insurance
    • IPO
    • Stocks
    • Mutual Funds
  • Partner with us
  • Trade School
  • Pricing

    • Pricing

    About Us

    • About Us

    Calculator

    • Calculators
    • Brokerage Calculator
    • MTF Calculator

    Resources

    • Blog
    • Webinars
    • Videos (YouTube)

    Updates

    • News
    • Trading Holidays
    • Cares
    • Media Coverage
    • Disclosures

    Support

    • Support
    • Refer & Earn
    CommunityCareers
Login

    Start Investing in Stocks₹0 Account Opening

    +91
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsYes BankPC JewellerVodafone IdeaBillionbrainsTata Tele. Mah.MoneyviewM T N LHDFC BankSuzlon EnergyV2 RetailTata Gold ETFIndiabullsSamvardh. Mothe.Motisons JewelNip. India GoldGTL Infra.Tata Silver ETFJSW CementOla Electric
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?
    Shares
    Top Gainers Today52 Weeks High StocksHistorical Returns StocksShare Market TodayTop Losers TodayStocks Market NewsYes BankPC JewellerVodafone IdeaBillionbrainsTata Tele. Mah.MoneyviewM T N LHDFC BankSuzlon EnergyV2 RetailTata Gold ETFIndiabullsSamvardh. Mothe.Motisons JewelNip. India GoldGTL Infra.Tata Silver ETFJSW CementOla Electric
    Indices
    NIFTY 50NIFTY Midcap 100NIFTY 100NIFTY RealtySENSEXNIFTY AutoNIFTY PSU BankNIFTY FMCGNIFTY BANKNIFTY MIDCAP 150BSE EnergyNIFTY PharmaBSE 100 LargeCap TMCNIFTY NEXT 50NIFTY MetalBSE 500 QUALITY 50
    F&O
    Options Nifty 50Options BANK NIFTYOptions MIDCPNIFTYOptions FINNIFTYFutures Highest OIFutures OI GainersFutures OI LosersFutures Top Traded
    Mutual Funds
    Debt Mutual FundsBest Debt Mutual fundsBest Equity Mutual fundsBest Hybrid Mutual fundsBest MidCap Mutual fundsBest Multicap Mutual fundsBest Large Cap Mutual fundsBest Small Cap Mutual fundsBest ELSS Mutual fundsBest Contra Mutual fundsBest Value Mutual fundsBest Arbitrage Mutual fundsBest Dividend Yield Mutual fundBest Aggressive Mutual fundsBest Conservative Mutual funds
    Calculators
    SIP CalculatorBrokerage CalculatorHome Loan EMI CalculatorLumpsum CalculatorMargin CalculatorFD CalculatorSWP CalculatorMF CalculatorEMI CalculatorStep-Up SIP CalculatorPPF Calculator
    IPO
    What Is IPO?Open IPOsUpcoming IPOsHow to Apply for an IPOWhat is Grey Market Premium?

    Company
    • About Us
    • Work with Us
    • Terms and Conditions
    • EKYC Guidelines
    • Contact Us
    • Cares
    Apps and Products
    • ANT APP
    • ANT WEB
    • 1LYOptions
    • Trade School
    • TradingView
    • 1LyAlgos
    Calculators
    • Calculators
    • SIP Calculator
    • Mutual Funds Return Calculator
    • Brokerage Calculator
    • RMS Live Updates
    • Term Coverage Calculator
    Important Links
    • Pricing
    • KYC Tracker
    • Market News
    • Global Indices
    • Gold Rate
    • Silver Rate
    • Trading Holidays

    Alice Blue
    3rd Floor, M.R.B.Arcade, No. 153/2,
    Bagalur Main Rd, Dwarka Nagar,
    Yelahanka, Bengaluru, Karnataka
    560063
    FacebookLinkedInX (Twitter)YouTubeInstagramWhatsapp

    ISO 27001:2022 Alice Blue is Certified Information Security Management System (ISMS)

    ISO 22301:2019 Alice Blue is Certified Business Continuity Management System (BCMS)

    DownloadsCircularsBank DetailsLearn
    Trade on TradingViewGet it on Google PlayDownload on the App Store

    Attention Investors!
    Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.Prevent unauthorized transactions in your account update your mobile number/ email Id with your Stock Broker. Receive information of your transactions directly from Exchange on your mobile / email id at the end of the day.

    Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

    Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
    Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
    Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
    Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
    Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038

    COMPLIANCE OFFICER: SARAVANAN R | Mobile No: +91 91872 10670 | Email:[email protected]

    We hereby declare that we are doing PRO trading

    Procedure to file a complaint on SEBI SCORES / SMART ODR : Register on SEBI SCORES 2.0 / SMART ODR. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

    Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances. ODR Circular

    Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.

    For queries regarding account opening or activation, email to accountactivation@aliceblueindia.com and for fund updates, email to funds@aliceblueindia.com

    Disclaimer: Attention investors:1) Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. 2) Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. 3) Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. 4) For demat and trading account closure with AliceBlue, kindly visit https://aliceblueonline.com/support/closure-freezing-reactivation or “ANT APPLICATION” under your profile and click on Settings -> Account Closure section -> Initiate account closure.

    No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.

    Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).

    DND PolicyInvestor CharterLegal DocumentationPrivacy policyFeedbackAnnual ReturnsAdvisory for InvestorsE-votingMandatory Member Details

    Performance

    Historical price movement and trading activity

    Trading Data

    Today's High

    458.2

    Today's Low

    446.95

    Open

    453.8

    Previous Close

    449

    Volume

    336195

    Total Traded Value High

    152338801.35

    Technicals

    Price-based indicators and levels

    Indicators

    IndicatorValueSignal
    Relative Strength Index (RSI)+47.71Neutral
    MACD+0.15Bullish

    Support and Resistance Levels

    R3467.07
    R2462.63
    R1455.82
    S1444.57
    S2440.13
    S3433.32

    Moving Averages

    PeriodSMAEMA
    20D Moving Average454.47454.54
    50D Moving Average452.22451.46
    200D Moving Average409.12486.03
    Cohance Lifesciences Ltd

    Cohance Lifesciences Ltd

    NSE: COHANCE | BSE: 543064
    ₹433.55-15.45 (-3.44%)
    BuySell

    News

    India Ratings affirmed IND3+ rating on Rs 500 crore bank loans and IND2 rating on Rs 200 crore debentures

    13 Aug 2026

    Cohance Lifesciences Ltd announced credit rating actions from multiple agencies, including a withdrawal notification from an unspecified agency regarding previously assigned ratings, and a related action from CRISIL Ratings Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015; India Ratings and Research Private Limited affirmed its IND3+ rating on Rs 500 crore of Bank Loan Facilities with a Stable outlook, and its IND2 rating on Rs 200 crore of Non-Convertible Debentures, noting that the rating reflects; CARE Ratings upgraded the rating on the Rs 300 crore Term Loan from CARE A- to CARE A; India Ratings continues to maintain credit ratings on higher-limit credit facilities, while CRISIL has withdrawn its CRISIL A1+ rating on the Rs 100 crore Commercial Paper program upon maturity, and withdrawn the Lower Limit Facilities rating as per a letter dated 12 August 2026, stating that the facilities are adequately covered.

    Volumes spurt at Cohance Lifesciences Ltd counter

    23 Jun 2026

    Cohance Lifesciences Ltd registered volume of 234.51 lakh shares by 14:14 IST on NSE, a 41.19 fold spurt over two-week average daily volume of 5.69 lakh shares

    Piramal Pharma Ltd, Kirloskar Oil Engines Ltd, Vedanta Ltd, Neuland Laboratories Ltd are among the other stocks to see a surge in volumes on NSE today, 23 June 2026. Cohance Lifesciences Ltd registered volume of 234.51 lakh shares by 14:14 IST on NSE, a 41.19 fold spurt over two-week average daily volume of 5.69 lakh shares. The stock rose 13.55% to Rs.460.15. Volumes stood at 3.61 lakh shares in the last session. Piramal Pharma Ltd saw volume of 811.88 lakh shares by 14:14 IST on NSE, a 25.97 fold spurt over two-week average daily volume of 31.26 lakh shares. The stock increased 6.43% to Rs.168.70. Volumes stood at 27.1 lakh shares in the last session. Kirloskar Oil Engines Ltd saw volume of 112.23 lakh shares by 14:14 IST on NSE, a 24.16 fold spurt over two-week average daily volume of 4.64 lakh shares. The stock increased 3.75% to Rs.2,479.30. Volumes stood at 17.94 lakh shares in the last session. Vedanta Ltd saw volume of 1586.3 lakh shares by 14:14 IST on NSE, a 8.78 fold spurt over two-week average daily volume of 180.69 lakh shares. The stock dropped 8.34% to Rs.280.35. Volumes stood at 135.51 lakh shares in the last session. Neuland Laboratories Ltd recorded volume of 1.69 lakh shares by 14:14 IST on NSE, a 5.6 times surge over two-week average daily volume of 30124 shares. The stock gained 5.25% to Rs.18,128.00. Volumes stood at 16943 shares in the last session. Powered by Capital Market - Live News

    Cohance Lifesciences Ltd leads gainers in 'A' group

    23 Jun 2026

    Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.

    Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026. Cohance Lifesciences Ltd soared 14.81% to Rs 466.4 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 12.57 lakh shares were traded on the counter so far as against the average daily volumes of 64696 shares in the past one month. Piramal Pharma Ltd spiked 8.26% to Rs 171.75. The stock was the second biggest gainer in 'A' group. On the BSE, 24.21 lakh shares were traded on the counter so far as against the average daily volumes of 3.48 lakh shares in the past one month. Jain Irrigation Systems Ltd surged 6.44% to Rs 37.5. The stock was the third biggest gainer in 'A' group. On the BSE, 7.85 lakh shares were traded on the counter so far as against the average daily volumes of 2.62 lakh shares in the past one month. Aarti Pharmalabs Ltd exploded 6.02% to Rs 718.1. The stock was the fourth biggest gainer in 'A' group. On the BSE, 60419 shares were traded on the counter so far as against the average daily volumes of 12632 shares in the past one month. BASF India Ltd added 5.81% to Rs 3780.4. The stock was the fifth biggest gainer in 'A' group. On the BSE, 5862 shares were traded on the counter so far as against the average daily volumes of 1636 shares in the past one month. Powered by Capital Market - Live News

    Volumes soar at Cohance Lifesciences Ltd counter

    23 Jun 2026

    Cohance Lifesciences Ltd recorded volume of 9.61 lakh shares by 10:46 IST on BSE, a 12.91 times surge over two-week average daily volume of 74436 shares

    Kirloskar Oil Engines Ltd, Hero MotoCorp Ltd, Physicswallah Ltd, Prestige Estates Projects Ltd are among the other stocks to see a surge in volumes on BSE today, 23 June 2026. Cohance Lifesciences Ltd recorded volume of 9.61 lakh shares by 10:46 IST on BSE, a 12.91 times surge over two-week average daily volume of 74436 shares. The stock gained 17.17% to Rs.476.00. Volumes stood at 13142 shares in the last session. Kirloskar Oil Engines Ltd clocked volume of 6.55 lakh shares by 10:46 IST on BSE, a 6.69 times surge over two-week average daily volume of 97963 shares. The stock gained 5.61% to Rs.2,525.00. Volumes stood at 3.29 lakh shares in the last session. Hero MotoCorp Ltd registered volume of 72816 shares by 10:46 IST on BSE, a 5 fold spurt over two-week average daily volume of 14575 shares. The stock slipped 0.22% to Rs.4,973.90. Volumes stood at 9178 shares in the last session. Physicswallah Ltd witnessed volume of 37.3 lakh shares by 10:46 IST on BSE, a 4.64 times surge over two-week average daily volume of 8.04 lakh shares. The stock increased 1.82% to Rs.128.40. Volumes stood at 27.35 lakh shares in the last session. Prestige Estates Projects Ltd registered volume of 1.59 lakh shares by 10:46 IST on BSE, a 3.56 fold spurt over two-week average daily volume of 44636 shares. The stock rose 3.58% to Rs.1,566.20. Volumes stood at 1.02 lakh shares in the last session. Powered by Capital Market - Live News

    Cohance Lifesciences CFO Himanshu Agarwal resigns to pursue opportunity outside company

    18 Jun 2026

    Cohance Lifesciences announced that Himanshu Agarwal, whole-time director (WTD) and chief financial officer (CFO) has tendered his resignation to pursue a professional opportunity outside the organisation.

    According to the company's regulatory filing, Agarwal will be relieved from his duties with effect from the close of business hours on September 13, 2026. Agarwal served as a whole-time director and key managerial personnel (KMP) of the company. The resignation is not linked to any material concerns and has been submitted to enable him to pursue opportunities outside the organisation. The company has not yet announced a successor for the CFO role. Cohance Lifesciences, formerly Suven Pharmaceuticals, is an innovator-focused global CRDMO formed through the merger of Cohance Life Sciences into Suven Pharmaceuticals. It is a technology-driven, integrated CDMO platform offering development and manufacturing solutions across complex APIs, performance materials, agrochemicals, ADCs, oligonucleotides and advanced chemistries for global pharmaceutical and life sciences customers. The company's consolidated net profit tanked 66.8% to Rs 44.67 crore on 26.2% decline in revenue from operations to Rs 567.55 crore in Q4 FY26 over Q4 FY25. The scrip declined 2.42% to end at Rs 415.55 on the BSE. Powered by Capital Market - Live News

    Insider Activity

    Dr. Venkata Naga Kali Vara Prasada Raju VetukuriDirector
    Acquired
    713259
    Shares Worth
    ₹7,13,259
    Reported On12 May 2025
    ModeAllotment
    Jusmiral Holdings LimitedPromoter
    Acquired
    126538578
    Shares Worth
    ₹12,65,38,578
    Reported On12 May 2025
    ModeAllotment
    Trade now

    Overview

    Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE / BSE

    Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018. The name of the Company has been changed to Cohance Lifesciences Limited w.e.f. May 7, 2025. Cohance Lifesciences Ltd is an integrated Contract Development and Manufacturing Operations (CDMO) company serving the leading global life science and fine chemical majors. The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles. The Company is a CDMO that supports global life sciences industry and fine chemical majors in their NCE development endeavors. Its services include custom synthesis, process R&D, scale-up and contract manufacturing of intermediates, APIs and formulations. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry. During the year 2019-20, Suven Life Sciences Ltd. (SLSL) has transferred the CRAMS Business Undertaking Division to the Company through the Scheme of Arrangement (Demerger) approved by the Hon'ble NCLT, Hyderabad Bench now integrated with Contract Development and Manufacturing Operations (CDMO) business model of the Company. In terms of the sanctioned Scheme, the Company issued and allotted 1 (One) fully paid up equity share of face value of Re 1/- (Rupee One only) each of SPL for every 1 (One) fully paid up equity share of face value of Re 1/- (Rupee One only) each held by each shareholder in the Demerged Company (SLSL) as on the Record Date (i.e., 22nd January, 2020), thereby resulted in a mirror shareholding of SLSL in the Company. The equity shares of the Company were listed to trade w.e.f. 09th March, 2020. The Board of Directors in its meeting held on August 17, 2020 considered, approved and recommended an issue of bonus shares in the proportion of (1:1) one new equity share of the Company of Re 1 each for every one existing equity share of the Company of Re 1 each. The company has a massive Rs 320-crore capex plan. Suven has invested Rs 120 crore in 2019-20. The balance is to be invested in 2020-21. During the year 2019-20, the Company invested USD35 million in Rising Pharma Holdings, Inc., USA through its wholly owned subsidiary, Suven Pharma, Inc., USA. Suven Pharma, Inc., in USA was originally formed by Suven Life Sciences Ltd while pursuing various business opportunities in CRAMS business undertaking during the demerger transition period now integrated with CDMO business of the Company, as per the decisions taken by the Board of the Company and of the Demerged Company i.e., Suven Life Sciences Ltd, in accordance with the enabling provisions of Scheme of Arrangement as sanctioned by Hon'ble NCLT Hyderabad Bench. As a result, Suven Pharma, Inc., in USA has become wholly owned subsidiary of the company during the FY 2019-2020. As on 31 March 2020,the company has one subsidiary and one associate company under its roof. The company filed 11 ANDAs as on March 31, 2020 and three of those secured the green light from the regulator. The Board has allotted the Bonus shares at 1:1 ratio in its Board Meeting held on 29 September 2020. Accordingly the number of shares increased from 12,72,82,478 to 25,45,64,956.. In 2022, the Company filed 17 ANDAs of which 9 had received approvals and 8 products were launched up to March, 2022. During year 2022, Company acquired 100% stake in Casper Pharma Private Limited, a Hyderabad based SEZ unit and Casper Pharma became a Wholly Owned Subsidiary of the company. The Company acquired 67.5% stake in Sapala Organics Private Limited, making it a subsidiary of the Company w.e.f. July 12, 2024. The Company acquired 56% equity share capital of NJ Bio, Inc., making it a subsidiary effective from December 20, 2024. The wholly owned subsidiary, Casper Pharma Private Limited was merged into the Company and the Scheme of Amalgamation became effective from January 1, 2025. Similarly, Cohance Lifesciences Limited has merged with and into Suven Pharmaceuticals Limited w.e.f May 1, 2025. Pursuant to the Scheme of Amalgamation, Suven Pharmaceuticals Limited, the erstwhile Company allotted 12,80,02,184 equity shares of Rs 1 each to the shareholders of the Company on May 9, 2025.

    Fundamentals

    Financial strength and ownership structure

    Valuation & Ratios

    Market Capitalisation

    ₹11,549.70

    Price to Book (PB)

    2.95

    Price to Earnings (PE)

    64.51

    Return on Equity (ROE)

    3.97%

    Earnings Per Share (EPS)

    3.92

    Dividend Yield

    0.00%

    Financial Performance

    231.05
    219.82
    252.93
    488.08
    603.77
    676.23
    840.42
    549.31
    555.57
    544.55
    619.12
    422.26
    Sep
    '23
    Dec
    '23
    Mar
    '24
    Jun
    '24
    Sep
    '24
    Dec
    '24
    Mar
    '25
    Jun
    '25
    Sep
    '25
    Dec
    '25
    Mar
    '26
    Jun
    '26

    Shareholding Pattern

    57.49%
    57.49%
    57.49%
    57.48%
    Dec
    '25
    Mar
    '26
    Jun
    '26
    Sep
    '26